Warning: You are not logged in. Your IP address will be recorded in this page's edit history.
Free text:
{{ population diversity | geno1=(C;C) | geno2=(C;G) | geno3=(G;G) | CEU | 4.7 | 32.8 | 62.5 | HCB | 2.2 | 40.0 | 57.8 | JPT | 11.1 | 33.3 | 55.6 | YRI | 3.2 | 27.0 | 69.8 | ASW | 0.0 | 0.0 | 0.0 | CHB | 2.2 | 40.0 | 57.8 | CHD | 0.0 | 0.0 | 0.0 | GIH | 0.0 | 0.0 | 0.0 | LWK | 0.0 | 0.0 | 0.0 | MEX | 0.0 | 0.0 | 0.0 | MKK | 0.0 | 0.0 | 0.0 | TSI | 0.0 | 0.0 | 0.0 | HapMapRevision=28 }} [[rs17036314]] is a SNP in the peroxisome proliferator-activated receptor gamma [[PPARG]] gene. In a 4 year study of 479 overweight individuals with impaired glucose tolerance (IGT) who participated in the Finnish Diabetes Prevention Study (DPS), carrying a [[rs17036314]](C) allele predicted conversion to [[type-2 diabetes]] (T2D) after adjustment for baseline fasting glucose (p=0.030). Increased physical activity reduced this risk.{{PMID|18091023}} {{on chip | 23andMe v3}} {{on chip | HumanOmni1Quad}}
Edit Summary
Cancel
